Anebulo Pharmaceuticals Valuation
| ANEB Stock | USD 1.59 0.03 1.85% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Anebulo Pharmaceuticals shows a prevailing Real Value of $2.61 per share. The current price of the firm is $1.59. Our model approximates the value of Anebulo Pharmaceuticals from analyzing the firm fundamentals such as current valuation of 63.92 M, and Return On Equity of -1.14 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Anebulo Pharmaceuticals' valuation include:
Undervalued
Today
Please note that Anebulo Pharmaceuticals' price fluctuation is dangerous at this time. Calculation of the real value of Anebulo Pharmaceuticals is based on 3 months time horizon. Increasing Anebulo Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Anebulo Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anebulo Stock. However, Anebulo Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.59 | Real 2.61 | Target 6.0 | Hype 1.59 |
The real value of Anebulo Stock, also known as its intrinsic value, is the underlying worth of Anebulo Pharmaceuticals Company, which is reflected in its stock price. It is based on Anebulo Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Anebulo Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Anebulo Pharmaceuticals helps investors to forecast how Anebulo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anebulo Pharmaceuticals more accurately as focusing exclusively on Anebulo Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Anebulo Pharmaceuticals' intrinsic value based on its ongoing forecasts of Anebulo Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Anebulo Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Anebulo Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Anebulo Pharmaceuticals Cash |
|
Anebulo Valuation Trend
Comparing Anebulo Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Anebulo Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Anebulo Pharmaceuticals Total Value Analysis
Anebulo Pharmaceuticals is presently forecasted to have valuation of 63.92 M with market capitalization of 42.79 M, debt of 260.58 K, and cash on hands of 14.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Anebulo Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
63.92 M | 42.79 M | 260.58 K | 14.55 M |
Anebulo Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Anebulo is to check how much profit was generated for every dollar of assets it reports. Anebulo Pharmaceuticals shows a negative utilization of assets of -0.66 percent, losing $0.006597 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Anebulo Pharmaceuticals shows how unproductive it operates for each dollar spent on its assets.Anebulo Pharmaceuticals Ownership Allocation
Anebulo Pharmaceuticals holds a total of 25.93 Million outstanding shares. Anebulo Pharmaceuticals shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.22 percent of Anebulo Pharmaceuticals outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Anebulo Pharmaceuticals Profitability Analysis
Net Loss for the year was (8.2 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Anebulo Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Anebulo Pharmaceuticals and how it compares across the competition.
About Anebulo Pharmaceuticals Valuation
The stock valuation mechanism determines Anebulo Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Anebulo Pharmaceuticals. We calculate exposure to Anebulo Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Anebulo Pharmaceuticals's related companies.Anebulo Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 25.8 M |
Anebulo Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Anebulo Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Anebulo we look at many different elements of the entity such as Anebulo's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Anebulo Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Anebulo Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Anebulo Pharmaceuticals' worth.Complementary Tools for Anebulo Stock analysis
When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |